OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
Anthony DiPiazza, Sarah R. Leist, Olubukola M. Abiona, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1869-1882.e6
Open Access | Times Cited: 87
Anthony DiPiazza, Sarah R. Leist, Olubukola M. Abiona, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1869-1882.e6
Open Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 210
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 210
Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 117
Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 117
Characterization of nanoparticles-based vaccines for COVID-19
Giuditta Guerrini, Davide Magrì, Sabrina Gioria, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 6, pp. 570-576
Open Access | Times Cited: 103
Giuditta Guerrini, Davide Magrì, Sabrina Gioria, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 6, pp. 570-576
Open Access | Times Cited: 103
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 92
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 92
Stopping pandemics before they start: Lessons learned from SARS-CoV-2
A.M. Edwards, Ralph S. Baric, Erica Ollmann Saphire, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1133-1139
Open Access | Times Cited: 82
A.M. Edwards, Ralph S. Baric, Erica Ollmann Saphire, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1133-1139
Open Access | Times Cited: 82
Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
Role of T cells in severe COVID-19 disease, protection, and long term immunity
Julia Maret Hermens, Can Keşmir
Immunogenetics (2023) Vol. 75, Iss. 3, pp. 295-307
Open Access | Times Cited: 42
Julia Maret Hermens, Can Keşmir
Immunogenetics (2023) Vol. 75, Iss. 3, pp. 295-307
Open Access | Times Cited: 42
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
Matthew Gagné, Kizzmekia S. Corbett, Barbara J. Flynn, et al.
Cell (2021) Vol. 185, Iss. 1, pp. 113-130.e15
Open Access | Times Cited: 73
Matthew Gagné, Kizzmekia S. Corbett, Barbara J. Flynn, et al.
Cell (2021) Vol. 185, Iss. 1, pp. 113-130.e15
Open Access | Times Cited: 73
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4333-4346.e14
Open Access | Times Cited: 45
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4333-4346.e14
Open Access | Times Cited: 45
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
Emily A. Voigt, Alana Gerhardt, Derek Hanson, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Emily A. Voigt, Alana Gerhardt, Derek Hanson, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Antiviral Research (2022) Vol. 204, pp. 105370-105370
Open Access | Times Cited: 42
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Antiviral Research (2022) Vol. 204, pp. 105370-105370
Open Access | Times Cited: 42
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model
Yanxia Chen, Can Li, Feifei Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 368-383
Open Access | Times Cited: 41
Yanxia Chen, Can Li, Feifei Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 368-383
Open Access | Times Cited: 41
Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization
Aileen Ebenig, Samada Muraleedharan, Julia Kazmierski, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111214-111214
Open Access | Times Cited: 41
Aileen Ebenig, Samada Muraleedharan, Julia Kazmierski, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111214-111214
Open Access | Times Cited: 41
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112326-112326
Open Access | Times Cited: 35
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112326-112326
Open Access | Times Cited: 35
Host range, transmissibility and antigenicity of a pangolin coronavirus
Yixuan J. Hou, S. Chiba, Sarah R. Leist, et al.
Nature Microbiology (2023) Vol. 8, Iss. 10, pp. 1820-1833
Open Access | Times Cited: 21
Yixuan J. Hou, S. Chiba, Sarah R. Leist, et al.
Nature Microbiology (2023) Vol. 8, Iss. 10, pp. 1820-1833
Open Access | Times Cited: 21
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1266-1283
Open Access | Times Cited: 12
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1266-1283
Open Access | Times Cited: 12
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
Lanying Du, Yang Yang, Xiujuan Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 4, pp. 1054-1074
Open Access | Times Cited: 31
Lanying Du, Yang Yang, Xiujuan Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 4, pp. 1054-1074
Open Access | Times Cited: 31
Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2
Kexin Yan, Troy Dumenil, Tang Bing, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 30
Kexin Yan, Troy Dumenil, Tang Bing, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 30
Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics
Gayatree Mishra, Vishal Prajapat, Debasis Nayak
Immunology (2023) Vol. 171, Iss. 2, pp. 155-169
Open Access | Times Cited: 17
Gayatree Mishra, Vishal Prajapat, Debasis Nayak
Immunology (2023) Vol. 171, Iss. 2, pp. 155-169
Open Access | Times Cited: 17
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk
Chengyi Li, Ryan M. Clauson, Luke F. Bugada, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9584-9604
Open Access | Times Cited: 5
Chengyi Li, Ryan M. Clauson, Luke F. Bugada, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9584-9604
Open Access | Times Cited: 5
Protective potential of structural proteins of the SARS-CoV-2 virus in protecting against COVID-19
Inna V. Dolzhikova, Daria M. Grousova, Ilya D. Zorkov, et al.
Journal of microbiology epidemiology immunobiology (2025) Vol. 101, Iss. 6, pp. 769-778
Open Access
Inna V. Dolzhikova, Daria M. Grousova, Ilya D. Zorkov, et al.
Journal of microbiology epidemiology immunobiology (2025) Vol. 101, Iss. 6, pp. 769-778
Open Access
Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in mice
Dylan T. Boehm, Kaitlyn M. Landreth, Emel Sen-Kilic, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Dylan T. Boehm, Kaitlyn M. Landreth, Emel Sen-Kilic, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation
Chengyi Li, Fang Ke, Shuai Mao, et al.
ACS Nano (2025)
Open Access
Chengyi Li, Fang Ke, Shuai Mao, et al.
ACS Nano (2025)
Open Access
